EUVIMEDDescobrir EUVIMED
Beobachtungsstudie

Upfront Surgery Versus Definitive Radiotherapy: Competing Risk Analyses in Early Stage Oropharyngeal Cancer

Liang Peng, Xue-Lan Zeng, Rui-Hua Fang, Ren-Qiang Ma, Wei-Ping Wen, Wei Sun

Otolaryngology–Head and Neck Surgery · 2023

DOI: 10.1002/ohn.245 ↗

At a glance

Beobachtungsstudie in Otolaryngology–Head and Neck Surgery, 2023. Written by Liang Peng and 5 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Major MEDLINE topics: Papillomavirus Infections, Oropharyngeal Neoplasms, Head and Neck Neoplasms. 19 references.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Objective

To compare the survival outcomes of early‐stage oropharyngeal cancer (OPC) patients treated with upfront surgery versus definitive radiotherapy (RT). Study Design Retrospective observational study.

Setting

Publicly available database.

Methods

A total of 1877 patients with T1‐2N0‐1M0 OPC were retrieved from the Surveillance, Epidemiology, and End Results database. Primary endpoints were cancer‐specific and noncancer mortalities, which were estimated using cumulative incidence function and compared by Gray's test. Univariate and multivariate Fine‐Gray subdistribution hazard models were used to estimate the effects of treatment modality on mortality. Subgroup analyses were performed in propensity‐score‐matched cohorts. All the analyses were conducted separately in human papillomavirus (HPV)‐negative and HPV‐positive cohorts.

Results

In the HPV‐negative cohort, definitive RT was independently associated with increased risk of cancer‐specific mortality (adjusted subdistribution hazard ratio [SHR], 2.29; 95% confidence interval [CI], 1.42‐3.68; p = .001) and noncancer mortality (adjusted SHR, 2.74; 95% CI, 1.50‐5.02; p = .001). In the HPV‐positive cohort, definitive RT and upfront surgery could achieve similar cancer‐specific and noncancer survival outcomes.

Conclusion

Upfront surgery is associated with lower cancer‐specific and noncancer mortality in HPV‐negative early‐stage OPC patients. However, in the setting of HPV‐positive early‐stage OPC with better prognosis, the 2 treatment modalities have similar efficacy in terms of cancer‐specific and noncancer survival outcomes. In the future, carefully designed prospective clinical trials are needed to confirm our findings.

Subjects

MeSH terms (MEDLINE)

Papillomavirus InfectionsOropharyngeal NeoplasmsHead and Neck NeoplasmsHumansProspective StudiesPrognosisRisk Assessment

Author keywords

competing riskearly stageoropharyngeal cancerradiotherapysurgery

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Institute of Otolaryngology-Head and Neck Surgery, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Department of Otolaryngology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong, Guangzhou, China.

Cite

APA

Peng, L., Zeng, X. L., Fang, R. H., Ma, R. Q., Wen, W. P., & Sun, W. (2023). Upfront Surgery Versus Definitive Radiotherapy: Competing Risk Analyses in Early Stage Oropharyngeal Cancer. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.245

Vancouver

Peng L, Zeng XL, Fang RH, Ma RQ, Wen WP, Sun W. Upfront Surgery Versus Definitive Radiotherapy: Competing Risk Analyses in Early Stage Oropharyngeal Cancer. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.245

BibTeX
@article{Peng2023,
  author = {Peng, Liang and Zeng, Xue-Lan and Fang, Rui-Hua and Ma, Ren-Qiang and Wen, Wei-Ping and Sun, Wei},
  title = {Upfront Surgery Versus Definitive Radiotherapy: Competing Risk Analyses in Early Stage Oropharyngeal Cancer},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2023},
  doi = {10.1002/ohn.245}
}
Start for free →